The XLV is breaking out after testing the $147-$148 area as resistance since late February. It finally broke out recently and came back down to retest the area as support yesterday, successfully. 1st Upside target is $157, followed by $162 for a secondary target. As markets are falling this week, healthcare typically does well in a bear market, so this breakout makes sense. Also, volume has gone up with the breakout, confirming price action
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.